Brainsway Deep TMS Therapy - for Brain Disorder Treatment

Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression

This open label study examines the clinical value of Brainsway Deep TMS (Transcranial Magnetic Stimulation) as an augmenting tool for treatment-resistant depression (TRD; n=17). In this study, 4 weeks of daily deep TMS sessions led to high levels of response and remission rates, significant alleviation of symptoms, and improved quality of life. The study shows that Deep Transcranial Magnetic Stimulation is effective, safe and relatively well tolerated as an augmenting tool for antidepressants in severe TRD.


© Brainsway Ltd.® 2014 | All rights reserved. Patients Portal · Brainsway Deep TMS · FDA Clearance · Disclaimer · Privacy Policy · Terms of Use